Advanced Basal Cell Carcinoma
Treatment Patterns and Clinical Characteristics of Patients with Advanced Basal Cell Carcinoma in the Community Oncology Setting
... Advanced Basal Cell Carcinoma without Metastasis (ID #1). The patient was a white female, first diagnosed with BCC in 1990 at the age of 64. Her medical oncol- ogy chart begins in 2001, when ...
8
Differential pharmacology and clinical utility of sonidegib in advanced basal cell carcinoma
... from advanced basal cell carcinoma (BCC) have very limited treatment ...locally advanced BCC patients who are not candidates for surgery or radiation ...of advanced BCC or ...
6
Safety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinoma
... with advanced basal cell carcinoma (aBCC), including locally advanced (laBCC) or metastatic (mBCC) ...with basal cell carcinoma nevus syndrome (BCCNS) [1, ...
7
Profile of vismodegib and its potential in the treatment of advanced basal cell carcinoma
... The Hh pathway is critical to the development of BCC. Mutations in this pathway are seen in virtually all patients with BCC. Inhibition of this pathway with the SMO inhibitor, vismodegib, leads to significant responses ...
7
Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma
... because advanced BCC can lead to emotional or psychological stress, in turn impacting a patient’s ...of advanced BCC and a favorable benefit-to-risk profile was noted for most ...
8
Vismodegib Provides a Novel Treatment for Advanced Basal Cell Carcinoma
... ed with either 150 mg or 270 mg per day depending on dose availability. A second cohort of 16 patients with solid tumors, 10 of which had BCC, was added to study a new 150 mg oral formulation of vismodegib [13]. Out of ...
5
Advanced basal cell carcinoma, the hedgehog pathway, and treatment options – role of smoothened inhibitors
... Data to date support a palliative but not curative role for these agents in the treatment of locally advanced, unresectable, or metastatic BCC. However, the impact of vismodegib on survival should not be ...
12
Spotlight on vismodegib in the treatment of basal cell carcinoma: an evidence-based review of its place in therapy
... locally advanced basal cell carcinoma (laBCC) that have recurred following surgery or for those who are not good candidates for surgery (risk/benefit ratio is against patient’s benefit, either ...
7
Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials
... with basal cell carcinoma (BCC) nevus syndrome (BCCNS), aberrant activation of the Hedgehog (Hh) pathway is a key pathogenic driver in BCC [1, ...unresectable advanced BCCs (aBCCs) that are ...
5
Basal Cell Carcinoma of the Skin to Tirana-Albania
... Giant BCC is a rare variant that infiltrates extra dermal structures such as bone, muscle and cartilage. The American Joint Committee on Cancer defines Giant BCC as a tumor larger than 5cm; fortunately only one percent ...
5
Basal cell carcinoma: 10 year experience with electrochemotherapy
... Electrochemotherapy was successfully applied in all cases, with no serious adverse events. Overall, we observed a 50% CR rate after a single ECT cycle, with sig- nificantly higher clearance rates in younger patients with ...
12
Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
... sebaceous carcinoma and brain ...in advanced cutaneous melan- oma [17], basal cell carcinoma [18], merkel cell carcinoma [19], and other tumors ...
7
Local facial flaps: a workhorse for reconstruction of facial malignancies defects
... of SCC. 1 Risk factors for BCC include fair skin type, sun exposure, ionising radiation, advanced age, immunosuppression. 2 Facial malignancy are mostly curable when detected and treated early. 3 Various treatment ...
5
Metatypical basal cell carcinoma: a clinical review
... ical carcinoma was found in 68% of cases, striking mainly younger males (66%; average age of ...metatypical carcinoma was found in 32% of cases, 62% were males (average age of ...
6
ARLTS1 polymorphisms and basal cell carcinoma of the skin
... Basal cell carcinoma (BCC) is the most common skin neoplasm, accounting for over 75% of all skin cancers [1, 2]. Though BCC occurs mainly sporadically, multiple tumours with an early onset are ...
5
The Fifth Phakomatosis – A Case Report
... as basal cell nevus syndrome, multiple basal cell carcinoma syndrome, Gorlin syndrome, or hereditary cutaneomandibular polyonocosis, multiple nevoid basal cell ...
5
Basal cell carcinoma, squamous cell carcinoma and melanoma of the head and face
... squamous cell carcinoma compared with that of basal cell carcinoma and may thus be responsible for the different pattern of invasion found in these two tu- mours ...
7
ANGIOGENESIS ASSESSMENT IN BASAL CELL CARCINOMA
... prognostic indicator that correlates with outcome. Re cent studies have suggested that tumor angiogenesis ex pressed as the microvessel density within and in areas adjacent to the tumor stroma interface significantly ...
6
Profile of eye lid lesions over a decade: a histopathological study from a tertiary care center in South India
... cases), basal cell adenoma and trichoepithelioma (1 case each) were ...granular cell tumor, benign fibrous histiocytoma, lipoma and nerve sheath ...
6
-Oids: An Insight
... Myeloid means “pertaining to,” “derived from,” or “manifesting” certain features of the bone marrow. It has the appearance of myelocytes, but not derived from bone marrow. Myeloid leukemias can produce malignant cells ...
12